NEWS RELEASE Anavex Life Sciences Corp. (Nasdaq: AVXL)

New Post Public Reply Private Reply Replies (1) Message Board
fletch
NEWS RELEASE

Anavex Life Sciences Corp. (Nasdaq: AVXL) today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will present a corporate overview at the 18th Annual BIO CEO & Investor Conference.

A full copy of the press release is included below for your reference. For further information, please contact us at 1-866-505-2895, or via email at ir@anavex.com.

On behalf of Anavex,

Investor Relations
Anavex Life Sciences Corp.

Anavex to Present at 18th Annual BIO CEO & Investor Conference on February 9th 2016

New York, NY – February 2, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will present a corporate overview at the 18th Annual BIO CEO & Investor Conference.

Dr. Missling’s presentation is scheduled to take place on Tuesday, February 9, 2016 at 1:30 p.m. ET at the Waldorf-Astoria Hotel, Conrad Suite, in New York, NY. Investors may view Dr. Missling’s presentation via live webcast (http://www.veracast.com/webcasts/bio/ceoinvestor2016/85223495157.cfm) or access an archived version via Anavex.com.

The 18th Annual BIO CEO & Investor Conference is hosted by the Biotechnology Industry Organization. It is the largest independent investor conference focused on established and emerging publicly traded and select private biotech companies.

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer. Anavex’s lead drug candidates, ANAVEX 2-73 and ANAVEX PLUS, the combination of ANAVEX 2-73 and donepezil (Aricept®), are currently in a Phase 2a clinical trial for Alzheimer’s disease. The drug combination ANAVEX PLUS produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually. ANAVEX 2-73 is an orally available drug candidate that targets sigma-1 and muscarinic receptors and successfully completed Phase 1 with a clean data profile. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in convulsive epileptic animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others. Michael J. Fox Foundation (MJFF) for Parkinson’s Research has awarded Anavex a research grant to develop ANAVEX 2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX 2-73 into a Parkinson’s disease clinical trial. ANAVEX 3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions. Further information is available at www.anavex.com.

Anavex Life Sciences Corp. (AVXL) Stock Research Links

AVXL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SOTERIA Launches Cancer Hunt™ for Military Patients

Updated Category News Views 66

Breaking the Barriers for Our Military's Cancer Fight Diving into the world of precision medicine, SOTERIA Precision Medicine Foundation has sparked a revolution with Cancer Hunt™. It's staggering to think about the piles of bureaucracy and insurance red tape that often stand between cancer patients and life-saving care. Especially when those patients are veterans or...

Continue Reading
Barco Brings HDR Cinema Home with Kinepolis Kortrijk

Updated Category News Views 230

A New Chapter in Cinema Projection Ah, Belgium, the land of waffles and apparently, cutting-edge cinema tech. That's right, Barco is bringing their HDR by Barco system to its own backyard in Kortrijk, teaming up with Kinepolis to shake things up. It's not just any expansion—it's a homecoming of sorts. The company's laser cinema magic has already made face time in the...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 39

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Banco Santander's Troubles: Legal Heat on SAN

Updated Category News Views 129

Brazilian Turbulence Shakes Banco Santander Imagine getting hit twice in a single week, once by a surprise election result and again by numbers that don't add up. That's the gut-wrenching scenario Banco Santander's (NYSE: SAN) investors are facing. After Brazil's unexpected election outcome, investor jitters translated into a 3.7% drop on October 26, 2026. Not two days...

Continue Reading
JAS Hits Top 1% in EcoVadis Sustainability Rankings

Updated Category News Views 57

A Platinum Performance in EcoVadis Ratings JAS Worldwide, hustling around in the logistics and supply chain sector, just nailed a spot in the much-coveted top 1% bracket for sustainability according to EcoVadis. We’re talking about a company that’s not only steering the mammoth ships of logistics but now it’s also wearing sustainability like a crown. This...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 0

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
Birth Injury Lawsuit Secures $19.1M Award in Michigan

Updated Category News Views 30

Legal Triumph for Sokolove's Birth Injury Case There are days when you see a win in the courtroom and think maybe, just maybe, justice ain't just a fairytale. Today, that thought knocks heavier with news rolling out of Michigan—an astronomical $19.1 million awarded to a family by a federal judge after a botched birth led to lifelong medical issues. You've got Sokolove...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 98

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
Cohere's CAD $7 Billion Raise Signals AI Power Shift

Updated Category News Views 149

Changing the Game: Cohere's Massive Series E Raise There's a seismic shift happening up north, and it’s not the aurora borealis. Cohere just announced the initial close of a staggering CAD $7 billion Series E funding round, eyeing a CAD $35.7 billion valuation. If it pans out, it’d be the kind of cash grab that's never been seen in Canadian tech history. Why This...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 115

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming $1000 Into $9,100 With This Top Stock

Updated Category News Views 40

Transform Your Investment with Old Dominion Freight Line Investors looking for strong returns often turn their attention to stocks that show consistent performance over the years. One such stock is Old Dominion Freight Line (NASDAQ: ODFL), which has impressively surpassed market performance over the last decade. With an average annual return of 24.38%, ODFL has...

Continue Reading
Focus Health Expands Medical Weight Loss Clinic in Texas

Updated Category News Views 14

Expanding Options at Irving Health & Wellness Clinic In Irving, Texas, Focus Health is shaking things up with a big fat expansion of its Irving Health & Wellness Clinic’s offerings. They're not just pumping out more of the same old same old. They're blending medical weight loss magic with aesthetic services to give folks in Dallas-Fort Worth a one-stop-shop for health...

Continue Reading
RTX Highlights Ongoing Supply Chain Challenges Amid Rising Demand

Updated Category News Views 157

RTX Corporation Discusses Supply Chain Challenges Post-Pandemic RTX Corporation (NYSE: RTX) is experiencing a decline in its share price due to ongoing issues across global supply chains, particularly in the aerospace sector stemming from the COVID-19 pandemic. Recent reports reveal significant labor shortages in high-demand jet production lines, emphasizing the urgency...

Continue Reading
Meta Platforms Inc's Challenge with Scams Affecting Growth

Updated Category News Views 212

Meta Platforms Inc and the Challenges with Scam Advertisements Meta Platforms Inc (NASDAQ: META) has recently come under scrutiny for its alleged complicity in allowing fraudulent advertisements to thrive across its popular platforms, including Facebook, Instagram, and WhatsApp. Reports indicate that the company was aware of these deceptive practices but chose not to take...

Continue Reading
Mint Incorporation Limited's Successful Market Entry with IPO

Updated Category News Views 113

Mint Incorporation Limited's Initial Public Offering Overview Mint Incorporation Limited (NASDAQ:MIMI), an emerging player in the interior design and fit-out industry, has successfully concluded its initial public offering (IPO). The company, based in Hong Kong, offered approximately 1,750,000 Class A ordinary shares at the price of $4.00 each, with trading officially...

Continue Reading